386 related articles for article (PubMed ID: 17064967)
1. Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels.
Iskit AB; Erkent U; Ertunc M; Guc MO; Ilhan M; Onur R
Vascul Pharmacol; 2007 Feb; 46(2):129-36. PubMed ID: 17064967
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE
Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
[TBL] [Abstract][Full Text] [Related]
3. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
Tosaki A; Szerdahelyi P; Engelman RM; Das DK
J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
[TBL] [Abstract][Full Text] [Related]
5. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
Sun W; Wainwright CL
Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
[TBL] [Abstract][Full Text] [Related]
6. K(ATP)-channel activation: effects on myocardial recovery from ischaemia and role in the cardioprotective response to adenosine A1-receptor stimulation.
Ford WR; Lopaschuk GD; Schulz R; Clanachan AS
Br J Pharmacol; 1998 Jun; 124(4):639-46. PubMed ID: 9690854
[TBL] [Abstract][Full Text] [Related]
7. Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rat heart: the role of alpha-adrenergic stimulation and K(ATP) channels.
Ravingerová T; Pancza D; Ziegelhoffer A; Styk J
Physiol Res; 2002; 51(2):109-19. PubMed ID: 12108920
[TBL] [Abstract][Full Text] [Related]
8. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
Tosaki A; Engelman DT; Engelman RM; Das DK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
[TBL] [Abstract][Full Text] [Related]
9. Effect of glimepiride and glibenclamide, inhibitors of ATP-dependent K(+)-channel, on ischaemia-reperfusion induced arrhythmias in rats.
Bozdogan O; Leprán I; Papp JG
Acta Physiol Hung; 1996; 84(3):265-6. PubMed ID: 9219599
[TBL] [Abstract][Full Text] [Related]
10. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels.
Johansen D; Ytrehus K; Baxter GF
Basic Res Cardiol; 2006 Jan; 101(1):53-60. PubMed ID: 16328106
[TBL] [Abstract][Full Text] [Related]
11. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
[TBL] [Abstract][Full Text] [Related]
12. Tissue selectivity of antidiabetic agent nateglinide: study on cardiovascular and beta-cell K(ATP) channels.
Hu S; Wang S; Dunning BE
J Pharmacol Exp Ther; 1999 Dec; 291(3):1372-9. PubMed ID: 10565863
[TBL] [Abstract][Full Text] [Related]
13. The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.
Tawfik MK; Abo-Elmatty DM; Ahmed AA
Eur Rev Med Pharmacol Sci; 2009; 13(2):81-93. PubMed ID: 19499842
[TBL] [Abstract][Full Text] [Related]
14. Selective cardiac plasma-membrane K(ATP) channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion.
Vajda S; Baczkó I; Leprán I
Eur J Pharmacol; 2007 Dec; 577(1-3):115-23. PubMed ID: 17904545
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.
Pickkers P; Dorresteijn MJ; Bouw MP; van der Hoeven JG; Smits P
Circulation; 2006 Aug; 114(5):414-21. PubMed ID: 16864730
[TBL] [Abstract][Full Text] [Related]
16. The molecular site of action of K(ATP) channel inhibitors determines their ability to inhibit iNOS-mediated relaxation in rat aorta.
Wilson AJ; Clapp LH
Cardiovasc Res; 2002 Oct; 56(1):154-63. PubMed ID: 12237176
[TBL] [Abstract][Full Text] [Related]
17. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
[TBL] [Abstract][Full Text] [Related]
18. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury.
Pompermayer K; Amaral FA; Fagundes CT; Vieira AT; Cunha FQ; Teixeira MM; Souza DG
Eur J Pharmacol; 2007 Feb; 556(1-3):215-22. PubMed ID: 17182029
[TBL] [Abstract][Full Text] [Related]
19. Activation of peripheral delta2 opioid receptors increases cardiac tolerance to ischemia/reperfusion injury Involvement of protein kinase C, NO-synthase, KATP channels and the autonomic nervous system.
Maslov LN; Lishmanov YB; Oeltgen PR; Barzakh EI; Krylatov AV; Govindaswami M; Brown SA
Life Sci; 2009 May; 84(19-20):657-63. PubMed ID: 19245818
[TBL] [Abstract][Full Text] [Related]
20. Evidence for hypothalamic K+(ATP) channels in the modulation of glucose homeostasis.
Zhang Y; Zhou J; Corll C; Porter JR; Martin RJ; Roane DS
Eur J Pharmacol; 2004 May; 492(1):71-9. PubMed ID: 15145709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
